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Association of fish intake and smoking with
risk of rheumatoid arthritis and age of
onset: a prospective cohort study
Jeffrey A. Sparks1,2* , Éilis J. O’Reilly3,4, Medha Barbhaiya5, Sara K. Tedeschi1,2, Susan Malspeis1, Bing Lu1,2,
Walter C. Willett2,3,6, Karen H. Costenbader1,2 and Elizabeth W. Karlson1,2
Abstract
Background: Prior studies suggest that fish may be protective for rheumatoid arthritis (RA) risk perhaps through
the anti-inflammatory effect of omega-3 fatty acid, but this relationship has not been clearly established. Therefore,
we investigated fish intake and RA risk by serologic status, age of onset, and smoking using a prospective cohort
study with large sample size, repeated measures of dietary intake, and lengthy follow-up.
Methods: We studied fish intake and RA risk among 166,013 women in two prospective cohorts, the Nurses’ Health
Study (NHS, 1984–2014) and NHSII (1991–2015). Fish intake was assessed using food frequency questionnaires at
baseline and every 4 years. Incident RA during follow-up and serologic status were determined by medical record
review. Pooled Cox regression models estimated hazard ratios (HR) and 95% confidence intervals (CI) for RA (overall
and by serologic status and age at diagnosis) for fish intake frequency. We tested for a smoking-fish interaction for
RA risk.
Results: During 3,863,909 person-years of follow-up, we identified 1080 incident RA cases. Increasing fish intake was
not associated with all RA (≥4 servings/week: multivariable HR 0.93 [95%CI 0.67–1.28] vs. < 1 serving/month; p for
trend = 0.42), seropositive RA (p for trend = 0.66), or seronegative RA (p for trend = 0.45), but had increased risk for
RA diagnosed > 55 years old (p for trend = 0.037). Among women ≤55 years old, frequent fish intake (vs. infrequent)
had HRs (95%CIs) of: 0.73 (0.52–1.02) for all RA, 0.85 (0.55–1.32) for seropositive RA, and 0.55 (0.32–0.94) for seronegative
RA. Ever smokers with infrequent fish intake had highly elevated risk for RA onset ≤55 years (HR 2.59, 95%CI 1.65–4.06),
while ever smokers with frequent fish intake had modestly elevated RA risk (HR 1.29, 95%CI 1.07–1.57; vs. never
smokers/frequent fish intake; p for smoking-fish interaction = 0.039).
Conclusion: In this large prospective cohort study, we found no clear protective effect of fish or marine omega-3
fatty acid intake on RA risk, overall or by serologic status. We found that fish intake attenuated the strong association of
smoking for RA diagnosed ≤55 years of age, but this requires further study.
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Background
Progress continues to be made in identifying risk factors
for rheumatoid arthritis (RA) [1]. Environmental factors
may affect transitions from genetic risk to RA-related
autoantibody development and between asymptomatic
autoimmunity and clinical onset [2, 3]. While smoking is
an important RA risk factor, many individuals who de-
velop RA never smoked, so other factors likely contrib-
ute [4–8]. In particular, metabolic factors such as obesity
and diet may be important for earlier RA onset [9–14].
Fish intake may decrease RA risk based on the
anti-inflammatory properties of omega-3 polyunsatur-
ated fatty acids (PUFAs), such as eicosapentaenoic acid
(EPA), docosahexaenoic acid (DHA), and docosapentae-
noic acid (DPA) [15]. Omega-3 PUFAs may have pro-
tective biologic effects in the phases prior to the onset of
clinically-apparent RA [16–18]. After RA diagnosis, fish
may have beneficial effects on disease activity and pain
[19–22].
The association of fish intake with RA risk has been
investigated previously, some studies showing inverse as-
sociations while others had no association [23–29]. A
meta-analysis of fish intake and RA risk showed a reduc-
tion in RA risk by 20–24% (statistically non-significant)
for 1–3 servings of fish/week compared to less [30].
These studies may not have been able to detect a modest
association of dietary factors with RA, did not have data
on confounders such as smoking, or did not investigate
RA phenotypes based on serostatus or age at onset. No
previous study has evaluated whether fish intake and RA
risk may differ based on smoking status, the strongest
environmental RA risk factor.
Therefore, we investigated fish intake and RA risk
using the Nurses’ Health Study (NHS) and NHSII, two
prospective cohort studies with lengthy follow-up and
detailed dietary/covariate data. We hypothesized that in-
creasing fish intake and marine omega-3 PUFAs would
be associated with decreased RA risk, particularly
earlier-onset RA or seropositive RA. We further aimed
to investigate whether fish intake had a differential effect
on RA by smoking status. We hypothesized that
anti-inflammatory effects of fish intake may attenuate
the elevated RA risk for smokers.
Methods
Study population
The NHS and NHSII are prospective cohorts of US
women who were registered nurses at enrollment. The
NHS enrolled 121,700 women aged 30–55 years in 1976;
the NHSII enrolled 116,670 women aged 25–42 years in
1989. In both cohorts, women answered questionnaires
at baseline and every 2 years to collect data on lifestyle,
family history, diet, diagnoses, and medications.
In this study, the baseline for analysis in the NHS &
NHSII were 1984 & 1991, respectively, when a compre-
hensive Food Frequency Questionnaire (FFQ) was first
introduced. We excluded participants who reported a
diagnosis of RA or other connective tissue disease
(CTD) prior to the 1984 or 1991 questionnaires and
those who did not answer the baseline FFQ. A total of
76,540 women in the NHS and 89,473 women in the
NHSII were included. All aspects of the study the study
comply with the Declaration of Helsinki and were ap-
proved by the Partners HealthCare Institutional Review
Board.
Dietary assessments
We used a semi-quantitative FFQ to measure food in-
take over the previous year [11, 31]. The FFQ has proven
validity and reproducibility compared to food diaries and
recall for a spectrum of dietary/nutritional factors [32,
33]. The FFQ ranks frequency of food/beverages on a
scale ranging from never or < 1/month to ≥6 servings/
day. Dietary intakes were assessed in the NHS in 1984,
1986, and every 4 years until 2010. In the NHSII, the
FFQ was administered in 1991 and every 4 years until
2011. We used cumulative average intake to reflect
long-term consumption and to reduce measurement
error. For each questionnaire cycle evaluating RA risk,
cumulative average intake was calculated by averaging
the repeated dietary measure from baseline until that
cycle. The cumulative average intake variable was
time-varying such that all available dietary measures at
each time point were taken into consideration to predict
RA risk in the subsequent questionnaire cycle. For ex-
ample, only the fish intake measured at baseline in 1984
was considered for RA risk in the window of 1984 to
1986 in the NHS since no previous measures were avail-
able at that time point. However, a total of 8 dietary
measures were used for cumulative average variable on
the 2012 questionnaire cycle assessing for RA risk be-
tween 2012 and 2014. We did not analyze simple up-
dated time-varying exposures since short-term dietary
changes are less likely to impact chronic disease risk
than long-term dietary habits. For categorical variables,
the cumulative average intake was calculated as a con-
tinuous measure prior to categorization.
Our primary exposure was fish intake frequency. The
FFQ included four items related to fish intake: 1) dark
meat fish (mackerel, salmon, sardines, bluefish, or
swordfish, 3–5 oz; 84–140 g); 2) canned tuna (3–4 oz;
84–112 g); 3) other fish (3–5 oz; 84–140 g); and 4)
shrimp, lobster, or scallops as main dish. One fish item
was added in the 1994 & 1998 FFQs: breaded fish cakes,
pieces, or fish sticks (1 serving). We calculated the serv-
ings of total fish consumed at each questionnaire cycle.
As the primary exposure, we considered five categories
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for total fish intake frequency: none to < 1/month, 1/
month to < 1/week, 1 to < 2.5/week, 2.5 to < 4/week,
and ≥ 4/week. We chose these categories based on rec-
ommendations of fish intake and their use in previous
reports investigating the association of fish intake with
chronic disease risk [34, 35]. To investigate a threshold
effect of fish intake on RA risk, we dichotomized this
variable into infrequent (none to < 1/month) and fre-
quent fish intake (≥1/month).
To investigate the effect of nutrients on RA risk, we
analyzed the effect of marine omega-3 PUFAs intake.
We considered marine omega-3 PUFAs as the sum of
EPA, DHA, and DPA from diet and supplements. We
did not consider these PUFAs separately since high cor-
relation limited assessment of their independent effects.
We calculated the total marine omega-3 PUFAs in each
cycle as previously described [36]. Since there are no
clear cutpoints for omega-3 PUFAs and RA risk, we ana-
lyzed quartiles of marine omega-3 PUFA intake.
Identification of incident RA
Women who self-reported RA or other CTD were ad-
ministered a screening questionnaire [37]. For those
who screened positive, medical records were obtained to
verify the diagnosis and collect symptom/diagnosis dates
and serostatus. All records were reviewed by two rheu-
matologists and all cases had RA by accepted criteria
[38, 39]. We defined seropositive RA as positive rheuma-
toid factor (RF) or anti-cyclic citrullinated peptide
(anti-CCP). We relied on clinical testing so were unable
to perform analyses based solely on anti-CCP serostatus
since this test was not used clinically when most of the
follow-up occurred. The end of follow-up was June 1,
2014 for the NHS and June 1, 2015 for the NHSII.
Covariates
Sociodemographic, lifestyle, and reproductive factors
Data on time-varying covariates were obtained through
biennial questionnaires. We considered variables that may
be associated with fish intake and RA based on prior lit-
erature [4, 9, 10, 40, 41]. Among past/current smokers, we
categorized smoking intensity as 1–14 cigarettes/day or ≥
15 cigarettes/day. We calculated smoking pack-years and
dichotomized as never/≤10 pack-years or > 10 pack-years
[8]. Body mass index (BMI) was categorized as under-
weight/normal (< 25.0 kg/m2), overweight (25 to < 30 kg/
m2), or obese (≥30 kg/m2). Physical activity was measured
using a validated survey and converted into weekly meta-
bolic equivalents [42]. We categorized parity and breast-
feeding duration into a single variable: nulliparous,
parous/breastfeeding for none to < 1month, parous/
breastfeeding for 1 to < 12months, or parous/breastfeed-
ing ≥12months. Menopausal status and postmenopausal
hormone (PMH) use was categorized as: premenopausal,
postmenopausal/never PMH use, or postmenopausal/ever
PMH use. We considered household income derived from
the US Census tract median income at the level of zip
code, categorized into quartiles.
Other dietary factors
Energy intake was obtained by summing the daily nutri-
tional content of all FFQ items as a continuous variable
(kilocalories/day). Alcohol intake was categorized as:
none to < 5 g/day, 5 to < 10 g/day, or ≥ 10 g/day. In ana-
lyses that included marine omega-3 PUFAs, we also in-
cluded other PUFA types (alpha-linoleic acid, omega-6
PUFAs), fatty acids (trans, saturated, and monounsatu-
rated), and macronutrients (protein and carbohydrates)
as continuous variables (g/day).
Statistical analysis
We described participants in each cohort according to the
baseline distribution of five categories of fish intake using
mean and standard deviation (SD) for continuous vari-
ables and proportions for categorical variables. We pooled
both cohorts into a single analysis to improve statistical ef-
ficiency given planned secondary and interaction analyses
with low numbers of subgroup outcomes.
Since we previously found differences in metabolic/
dietary RA risk factors related to age ≤ 55 or > 55 years
old (chosen related to clinical observations of differing
RA phenotypes related to age at diagnosis and as an ap-
proximation of menopause), we compared clinical char-
acteristics of RA cases by these ages at diagnosis [9, 11,
13, 14]. Median time from first symptoms to diagnosis
were compared by the Wilcoxon-rank sum test. We
compared the distribution of 1987 ACR criteria using
the chi-square test.
The primary analysis assessed the association of 5 cat-
egories of fish intake with all RA risk as well as by seros-
tatus and stratified by age at diagnosis (≤55 or > 55
years). Other secondary analyses investigated the associ-
ation of fish as a binary variable (frequent [≥1 serving/
month] or infrequent [none to < 1 serving/month] in-
take) with RA risk overall and by serostatus and age
stratification. We used Cox proportional hazards models
to obtain hazard ratios (HR) and 95% confidence inter-
vals (CI) for the association of fish intake with RA risk,
with the lowest category of fish intake as the reference
group. Person-years commenced from the return date of
the baseline questionnaire to the end of follow-up,
death, or censor, whichever came first. Women were
censored for self-reported CTD not confirmed to be RA.
We considered the lowest category of fish intake as the
reference group. In base models, we adjusted for age,
questionnaire period, cohort, and energy. We built mul-
tivariable models based on the primary analysis and in-
cluded covariates that were associated with both fish
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intake and RA risk. The final multivariable model in-
cluded the base factors as well as median household in-
come, smoking, BMI, and alcohol intake. We calculated
p for trend using the median value within each category
as a continuous variable in the model.
We investigated the association of quartiles of marine
omega-3 PUFAs with the RA outcomes. We considered
women in the lowest quartile of intake as the reference
group. In these regression models, we also adjusted for
other types of PUFAs, fatty acids, and macronutrients to
determine the independent of effect of marine omega-3
fatty acids. Since total energy was included, we did not
additionally include carbohydrates since all other macro-
nutrients were present.
LLastly, we investigated an interaction between
smoking and fish intake, both considered as binary
variables (never/ever smoking and frequent/infrequent
fish intake). We investigated all RA, as well as strati-
fied analyses based on age at diagnosis (≤55 or > 55
years). We created a cross-classified variable as our
main exposure, with never smoking/frequent fish in-
take as the reference group. We obtained p for multi-
plicative interactions from an interaction term in the
model.
We verified the proportional hazards assumption in
all analyses by comparing nested models with and
without interaction terms of follow-up time and ex-
posure status. A two-sided p < 0.05 was considered
statistically significant.
Results
Baseline characteristics of both cohorts according to 5
categories of fish intake are shown in Table 1. In both
cohorts (n = 166,013), fish intake of none to < 1 serving/
month occurred infrequently (5.7% in NHS and 9.3% in
NHSII). Age, race, US region, and reproductive factors
were similar regardless of fish intake. Daily energy intake
increased as fish intake increased. Those who ate fish
frequently were more likely to be ever smokers and had
higher income, alcohol intake, and BMI compared to
those who infrequently ate fish.
During a total of 3,863,909 person-years of follow-up,
there were 1080 incident RA cases. Of these, 672
(62.2%) were seropositive and 408 (37.8%) were sero-
negative. Table 2 shows RA clinical characteristics at
presentation according to age at RA diagnosis. Women
with RA diagnosed at age ≤ 55 years tended to have more
1987 ACR criteria (p = 0.016) and were more likely to be
seropositive (p = 0.020) than women diagnosed with RA
at age > 55 years.
The association between 5 categories of cumulative
average fish intake and RA risk is shown in Table 3.
Compared to infrequent fish intake (none to < 1 serving/
month), there was no association with more frequent
fish intake categories and all RA risk. In the base model
adjusted for age, questionnaire period, energy, and co-
hort, women with fish intake ≥4 servings/week had HR
for all RA of 0.92 (95%CI 0.66–1.27; p for trend = 0.48).
In the multivariable model additionally adjusted for
household income, smoking, BMI, and alcohol intake,
the HR for all RA was 0.93 (95%CI 0.67–1.28; p for
trend = 0.42). We found no association of fish intake
with seropositive RA (p for trend = 0.66), seronegative
RA (p for trend = 0.45), and all RA among women aged
≤55 years (p for trend = 0.29). While there was no statis-
tically significant trend, the point estimate of the HR
tended to be < 1 compared to none to infrequent fish in-
take for all categories in all RA, seropositive RA, sero-
negative RA, and all RA diagnosed ≤55 years old.
However, increasing fish intake across 5 categories was
associated with increased RA risk among women aged >
55 years (p for trend = 0.037). In subgroup analyses,
there was no association across categories of fish intake
with risk of seropositive RA among women ≤55 years (p
for trend = 0.33) or seronegative RA ≤55 years (p for
trend = 0.99).
Table 4 shows the results evaluating a threshold effect
for RA risk where infrequent fish intake was considered
as none to < 1 serving/month and frequent fish intake
was ≥1 serving/month. Compared to infrequent fish in-
take, frequent intake was not associated with all RA
(multivariable HR 0.85, 95%CI 0.64–1.13), seropositive
RA (HR 0.86, 95%CI 0.60–1.22), or seronegative RA (HR
0.85, 95%CI 0.53–1.35). Among women aged ≤55 years,
frequent fish intake was significantly associated with de-
creased all RA risk in the base model (HR 0.71, 95%CI
0.50–1.00, p = 0.048). In the multivariable model, the as-
sociation of frequent fish intake with reduced RA risk
was similar but not statistically significant (HR 0.73,
95%CI 0.52–1.02, p = 0.066). In one subgroup, there was
a statistically significant protective effect of frequent fish
intake for seronegative RA diagnosed ≤55 years of age
(HR 0.55, 95%CI 0.32–0.94). Frequent fish intake was
not associated with RA diagnosed > 55 years (HR 1.14,
95%CI 0.69–1.88).
Table 5 shows the results investigating quartiles of
marine omega-3 PUFA (EPA, DHA, and DPA) intake
with RA risk. There was no association of quartiles of
marine omega-3 PUFAs with all RA (p for trend = 0.28),
seropositive RA (p for trend = 0.19), seronegative RA (p
trend = 0.92), or among those aged ≤55 years (p for
trend = 0.40). There was no association with RA among
those aged > 55 years in the base model (p for trend =
0.097), but the multivariable model was statistically sig-
nificant (p for trend = 0.031). There was no association
from lowest to highest quartile of marine omega-3 PUFA
intake with risk of seropositive RA among women ≤55
years (p for trend = 0.19) or seronegative RA among
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women ≤55 years (p for trend = 0.19) in these subgroup
analyses.
Fig. 1 shows the results comparing RA risk based on
smoking status and fish consumption. Ever smokers with
infrequent fish intake had increased all RA risk (HR
1.99, 95%CI 1.37–2.89) compared to never smokers with
frequent fish intake. However, there was no statistical
interaction between fish and smoking for all RA (p for
interaction = 0.086). There was a statistically significant
interaction between fish and smoking for RA risk among
women aged ≤55 years. In this subgroup, ever smokers
with infrequent fish intake had very elevated RA risk
(HR 2.59, 95%CI 1.65–4.06) while ever smokers with fre-
quent fish intake had modestly increased RA risk (HR
1.29, 95%CI 1.07–1.57; vs. never smokers with frequent
fish intake; p for interaction = 0.039). There was no
smoking-fish interaction among those aged > 55 years (p
for interaction = 0.73).
Discussion
In this prospective study investigating fish intake and
RA risk among 166,013 women with over 3.8 million
person-years of follow-up, we found that increasing fre-
quency of fish intake was not associated with overall RA
risk or serologic RA phenotypes. Unlike previous stud-
ies, we found no evidence for a protective association
between marine omega-3 PUFA intake and RA. In one
subgroup, we did find a modest inverse association of
fish intake above a threshold above 1 serving/month
with RA risk, but only for earlier onset seronegative RA
(age ≤ 55 years). While our results suggest that fish in-
take may attenuate the increased RA risk among ever
smokers in this younger age group, fish intake may actu-
ally increase RA risk among older individuals > 55 years
of age. Overall, these results do not support a strong ef-
fect of fish or omega-3 fatty acid intake on RA risk.
Our study adds to the literature of a relationship be-
tween fish intake and RA risk [30]. Several case-control
studies suggested that fish intake, particularly dark
meat/oily fish, was associated with decreased RA risk
[23–25, 28]. These studies may have been limited due to
recall bias and were conducted in coastal geographic
areas with high fish intake (US Pacific Northwest,
Greece, and Sweden) [23–25, 28]. Only one of these
case-control studies adjusted for smoking [28]. Two
studies investigated fish and seropositive RA risk but
were underpowered for definitive conclusions [24, 28].
Fish intake and RA risk was investigated previously in
cohort studies [26, 27, 29]. In a Danish study, fish intake
on a single FFQ was not associated with RA, but there
were few RA outcomes, so it may have been underpow-
ered [26]. The Swedish Mammography cohort that ana-
lyzed two FFQ assessments may have suggested a
modest, albeit statistically non-significant, decreased RA
risk for fish intake ≥1 serving/week (RR 0.71, 95%CI
0.48–1.04), but analyses were not stratified by age [29].
They found that omega-3 PUFA intake above the thresh-
old of the first quartile (> 0.21 g/day) was protective for
RA risk (RR 0.65, 95%CI 0.48–0.90) [29]. Our omega-3
PUFA intake analyses did not detect a protective effect.
While that study adjusted for smoking, the authors did
not stratify by age at diagnosis, and fish-smoking inter-
actions were not studied [29]. Our group previously in-
vestigated fish intake, among other dietary factors, and
RA risk in the NHS and found no association [27]. This
present report nearly doubles the number of incident
RA cases by extending follow-up by 12 years and includ-
ing the NHSII, allowing for increased power as well as
Table 2 Characteristics of 1080 incident rheumatoid arthritis cases at presentation based on diagnosis before or after 55 years of
age
RA diagnosed≤ 55 years (n = 491) RA diagnosed > 55 years (n = 589) p value
Median time from first symptoms to diagnosis, months (IQR) 7 (3, 13) 6 (2, 13) 0.17
Number of 1987 ACR criteria, % 0.016
4 45.2 53.5
5 43.0 34.8
6–7 11.8 11.7
Seropositivea, % 66.0 59.1 0.020
Radiographic changes, % 24.6 28.7 0.13
Hand arthritis, % 98.8 98.0 0.30
Symmetric arthritis, % 96.7 96.9 0.85
≥3 joint areas affected, % 95.8 93.5 0.090
> 1 h of morning stiffness, % 75.8 73.9 0.47
Rheumatoid nodules, % 10.0 8.8 0.52
a Seropositive was defined as positive rheumatoid factor and/or anti-cyclic citrullinated peptide on medical record review
ACR, American College of Rheumatology; IQR, interquartile range; RA, rheumatoid arthritis
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subgroup analyses of RA phenotypes and smoking-fish
interaction analyses. Despite adequate sample size and
number of outcomes, our study did not find a protective
effect on seropositive RA.
Several investigations in the Studies of the Etiology of
RA (SERA) suggest that omega-3 PUFAs may be par-
ticularly important in the preclinical transitions preced-
ing clinical RA presentation. Among those with the
shared epitope or RA-related autoantibodies, omega-3
supplement use and erythrocyte-bound PUFAs were in-
versely associated with anti-CCP, RF positivity, and in-
flammatory arthritis [16–18]. Another SERA study
reported that early age and smoking are both important
factors for inflammatory arthritis [43]. Our results sug-
gest that fish intake may be relatively more beneficial
among younger/middle-aged women who were ever
smokers. Since smokers may have increased systemic
inflammation, long-term fish intake may exert effects by
lowering inflammation once present due to smoking or
other factors. A European nested case-control study
showed that erythrocyte-bound omega-6 PUFAs, but not
omega-3 PUFAs, were inversely associated with RA risk,
so the effect of PUFAs on RA is still unclear [44]. Given
the number of comparisons pursued in our study, the
finding of the smoking-fish interaction should be consid-
ered as exploratory. While erythrocyte-bound assays and
intake on FFQ have both been validated as measures of
omega-3 PUFAs, they are only modestly correlated with
each other, and it is unclear how much fish intake is
needed for a meaningful increase in erythrocyte mea-
sures of omega-3 PUFAs [32, 45]. Therefore, the differ-
ences in our findings and the studies in SERA may be
related to these different measures of omega-3 PUFAs in
addition to studying different outcomes (surrogates of
Table 3 Hazard ratios for rheumatoid arthritis phenotypes according to categories of cumulative average total fish intake in the
Nurses’ Health Study and Nurses’ Health Study II (n = 166,013)
Total fish servings
None to < 1/month 1/month to < 1/week 1 to < 2.5/week 2.5 to < 4/week ≥4/week p for
trendHR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI)
All RA
Cases/person-years 53/185,861 175/705,447 513/1,888,251 200/649,928 139/434,424
Age-adjusted modela 1.00 (Ref) 0.82 (0.60–1.11) 0.83 (0.62–1.11) 0.87 (0.64–1.19) 0.92 (0.66–1.27) 0.48
Multivariable modelb 1.00 (Ref) 0.82 (0.60–1.12) 0.84 (0.63–1.12) 0.89 (0.65–1.22) 0.93 (0.67–1.28) 0.42
Seropositive RA
Cases/person-years 34/185,640 116/704,320 308/1,884,304 133/648,527 81/433,284
Age-adjusted modela 1.00 (Ref) 0.86 (0.59–1.27) 0.80 (0.56–1.15) 0.95 (0.64–1.39) 0.87 (0.57–1.31) 0.72
Multivariable modelb 1.00 (Ref) 0.86 (0.59–1.27) 0.82 (0.57–1.17) 0.97 (0.66–1.43) 0.88 (0.58–1.33) 0.66
Seronegative RA
Cases/person-years 19/185,340 59/703,876 205/1,883,542 67/648,136 58/432,966
Age-adjusted modela 1.00 (Ref) 0.74 (0.44–1.25) 0.88 (0.54–1.41) 0.76 (0.45–1.27) 0.99 (0.59–1.69) 0.48
Multivariable modelb 1.00 (Ref) 0.74 (0.44–1.25) 0.88 (0.55–1.42) 0.77 (0.46–1.29) 1.01 (0.59–1.71) 0.45
All RA among≤ 55 years
Cases/person-years 37/134,613 113/458,908 213/1,072,596 74/301,548 54/224,372
Age-adjusted modela 1.00 (Ref) 0.85 (0.59–1.24) 0.64 (0.45–0.91) 0.72 (0.48–1.08) 0.71 (0.46–1.10) 0.25
Multivariable modelb 1.00 (Ref) 0.86 (0.59–1.25) 0.66 (0.46–0.94) 0.75 (0.50–1.12) 0.72 (0.47–1.11) 0.29
All RA among > 55 years
Cases/person-years 16/52,659 62/252,365 300/828,551 126/352,538 85/211,857
Age-adjusted modela 1.00 (Ref) 0.82 (0.47–1.42) 1.19 (0.72–1.98) 1.19 (0.70–2.01) 1.30 (0.75–2.23) 0.043
Multivariable modelb 1.00 (Ref) 0.82 (0.47–1.42) 1.21 (0.73–2.00) 1.21 (0.71–2.05) 1.32 (0.76–2.27) 0.037
There were 1080 cases in 3,863,909 total person-years for all RA analyses. There were 672 cases in 3,856,074 total person-years for seropositive RA analyses
There were 408 cases in 3,853,860 total person-years for seronegative RA analyses. There were 491 cases in 2,192,037 total person-years for all RA among ≤55
years analyses. There were 589 cases in 1,697,970 total person-years for all RA among > 55 years analyses
The exposure period was 1984 to 2012 for cases occurring until 2014 in the NHS; the exposure period was 1991 to 2013 for cases occurring until 2015 in
the NHSII
a Adjusted for age, questionnaire period, cohort, and total energy intake (continuous)
b Multivariable models were adjusted for age, questionnaire period, cohort, total energy intake (continuous), median household income (quartiles), cigarette
smoking (never, past 1–14/day, past ≥15/day, current 1–14/day, current ≥15/day), body mass index category (underweight/normal, overweight, obese), and
alcohol intake (never to < 5, 5 to < 10, ≥10 g/day)
CI confidence interval, HR hazard ration, RA rheumatoid arthritis
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RA such as presence of RA-related autoantibodies in
SERA vs. onset of RA in our study).
Strengths of our study include a large sample size, long
follow-up, and many RA outcomes with detailed dietary/
covariate data. We were able to investigate fish intake
and risk of RA phenotypes based on serostatus and age
at diagnosis. We used a prospective cohort design, so
time-varying fish intake measures were collected prior
to RA onset and less likely to be affected by recall bias.
Women had multiple repeated measures of diet during
follow-up and we analyzed the cumulative average fish
intake to reflect long-term dietary intake. A recent study
showed that unaffected relatives of RA were patients un-
aware that fish intake may affect RA risk and were moti-
vated to change behaviors after a personalized RA risk
educational intervention [46, 47]. However, this dietary
recommendation may have at best only a modest effect
on RA risk.
Our study has limitations to consider. The cohorts in-
cluded mostly white and educated women who were
Table 4 Hazard ratios for rheumatoid arthritis phenotypes according to dichotomized cumulative average total fish intake in the
Nurses’ Health Study and Nurses’ Health Study II (n = 166,013)
Total fish servings
None to < 1/month (low) ≥1/month (high) p value
HR (95%CI) HR (95%CI)
All RA
Cases/person-years 53/185,861 1027/3,678,049
Age-adjusted modela 1.00 (Ref) 0.84 (0.64–1.11) 0.23
Multivariable modelb 1.00 (Ref) 0.85 (0.64–1.13) 0.27
Seropositive RA
Cases/person-years 34/185,640 638/3,670,434
Age-adjusted modela 1.00 (Ref) 0.84 (0.59–1.20) 0.34
Multivariable modelb 1.00 (Ref) 0.86 (0.60–1.22) 0.39
Seronegative RA
Cases/person-years 19/185,340 389/3,668,519
Age-adjusted modela 1.00 (Ref) 0.84 (0.53–1.34) 0.47
Multivariable modelb 1.00 (Ref) 0.85 (0.53–1.35) 0.48
All RA among≤ 55 years
Cases/person-years 37/134,613 454/2,057,424
Age-adjusted modela 1.00 (Ref) 0.71 (0.50–1.00) 0.048
Multivariable modelb 1.00 (Ref) 0.73 (0.52–1.02) 0.066
Seropositive RA among≤ 55 years
Cases/person-years 22/134,452 302/2,053,251
Age-adjusted modela 1.00 (Ref) 0.83 (0.53–1.29) 0.40
Multivariable modelb 1.00 (Ref) 0.85 (0.55–1.32) 0.47
Seronegative RA among≤ 55 years
Cases/person-years 15/134,186 152/2,051,358
Age-adjusted modela 1.00 (Ref) 0.54 (0.31–0.92) 0.024
Multivariable modelb 1.00 (Ref) 0.55 (0.32–0.94) 0.029
All RA among > 55 years
Cases/person-years 16/52,659 573/1,645,311
Age-adjusted modela 1.00 (Ref) 1.13 (0.69–1.87) 0.62
Multivariable modelb 1.00 (Ref) 1.14 (0.69–1.88) 0.60
aAdjusted for age, questionnaire period, cohort, and total energy intake (continuous)
bMultivariable models were adjusted for age, questionnaire period, cohort, total energy intake (continuous), median household income (quartiles), cigarette
smoking (never, past 1–14/day, past ≥15/day, current 1–14/day, current ≥15/day), body mass index category (underweight/normal, overweight, obese), and
alcohol intake (never to < 5, 5 to < 10, ≥10 g/day)
CI confidence interval, HR hazard ratio, RA rheumatoid arthritis
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healthy and working at baseline, so may not be
generalizable. However, about two-thirds of patients with
RA are women but it is unclear whether fish intake
would have a similar effect on RA risk for men. While
the FFQ has been widely used as a survey instrument to
collect dietary data, it may not be completely accurate.
Moreover, given the period of observation, fish con-
sumption was low and often in the form of tuna, rather
than other types of fresh fish, which likely has more
powerful effects on increasing omega-3 PUFA levels. We
were able to adjust for important covariates, such as
smoking and BMI, but residual confounding is still pos-
sible. While we found a modest inverse association be-
tween fish intake and RA risk among women ≤55 years
of age, we found no association of omega-3 PUFA intake
with RA, even among this subgroup. It is possible that
these could be chance findings related to multiple
comparisons, though we pre-specified hypotheses based
on literature [11, 43]. Our group has found differences
related to elevated BMI and other dietary factors for RA
occurring at less than 55 years which may be related to
biologic differences based on menopause [9, 11, 13, 14].
Most of the participants in the SERA studies investigat-
ing omega-3 PUFAs and RA outcomes were younger
than 55 years, but these studies were not specifically re-
stricted to premenopausal women [16–18]. Less than
10% of women in both cohorts were categorized as hav-
ing infrequent fish intake, so most women that were an-
alyzed met this threshold and there were only a few
cases that occurred in the infrequent fish intake cat-
egory. However, in the main analysis investigating 5 cat-
egories of fish intake, there was no clear effect of higher
categories of fish intake for reducing RA risk. We found
no protective association of fish intake with seropositive
Table 5 Hazard ratios for rheumatoid arthritis phenotypes according to quartiles of marine omega-3 polyunsaturated fatty acida
intake in the Nurses’ Health Study and Nurses’ Health Study II (n = 166,013)
Marine omega-3 polyunsaturated fatty acid intakea
Quartile 1 Quartile 2 Quartile 3 Quartile 4 p for
trendHR (95%CI) HR (95%CI) HR (95%CI) HR (95%CI)
All RA
Cases/person-years 251/945,683 269/969,619 279/980,365 281/968,243
Age-adjusted modelb 1.00 (Ref) 1.03 (0.87–1.22) 1.05 (0.88–1.24) 1.04 (0.88–1.24) 0.65
Multivariable modelc 1.00 (Ref) 1.05 (0.88–1.25) 1.09 (0.91–1.31) 1.12 (0.91–1.37) 0.28
Seropositive RA
Cases/person-years 167/943,993 153/967,552 177/978,198 175/966,331
Age-adjusted modelb 1.00 (Ref) 0.88 (0.70–1.09) 1.00 (0.81–1.23) 0.97 (0.79–1.21) 0.82
Multivariable modelc 1.00 (Ref) 0.92 (0.73–1.15) 1.08 (0.86–1.36) 1.12 (0.87–1.43) 0.19
Seronegative RA
Cases/person-years 84/943,360 116/967,367 102/977,670 106/965,464
Age-adjusted modelb 1.00 (Ref) 1.34 (1.01–1.77) 1.14 (0.86–1.53) 1.18 (0.89–1.58) 0.64
Multivariable modelc 1.00 (Ref) 1.31 (0.98–1.75) 1.12 (0.82–1.51) 1.14 (0.81–1.59) 0.92
All RA among≤ 55 years
Cases/person-years 125/565,147 139/564,890 120/548,635 107/513,366
Age-adjusted modelb 1.00 (Ref) 1.10 (0.87–1.41) 0.96 (0.75–1.24) 0.90 (0.69–1.17) 0.23
Multivariable modelc 1.00 (Ref) 1.10 (0.86–1.41) 0.98 (0.75–1.27) 0.93 (0.69–1.25) 0.40
All RA among > 55 years
Cases/person-years 126/386,863 130/411,627 159/438,231 174/461,250
Age-adjusted modelb 1.00 (Ref) 0.96 (0.75–1.23) 1.12 (0.89–1.42) 1.16 (0.92–1.47) 0.097
Multivariable modelc 1.00 (Ref) 1.00 (0.77–1.28) 1.20 (0.93–1.54) 1.29 (0.98–1.69) 0.031
aDietary and supplementary intake of eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), and docosapentaenoic acid (DPA) were considered as marine
omega-3 polyunsaturated fatty acids
bAdjusted for age, questionnaire period, cohort, and total energy intake (continuous)
cMultivariable models were adjusted for age, questionnaire period, cohort, total energy intake (continuous), median household income (quartiles), cigarette
smoking (never, past 1–14/day, past ≥14/day, current 1–14/day, current ≥14/day), body mass index category (underweight/normal, overweight, obese), alcohol
intake (never to < 5, 5 to < 10, ≥10 g/day), alpha-linolenic acid (g/d), trans fatty acids (g/d), saturated fatty acids (g/d), monounsaturated fatty acids (g/d), omega-6
polyunsaturated fatty acids (g/d), and protein (g/d)
CI confidence interval, HR hazard ratio, RA rheumatoid arthritis
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RA and actually found an increased risk for RA diag-
nosed at > 55 years, both contrary to our hypothesis and
previous studies [16, 24].
Conclusions
In conclusion, our study did not find an association of
fish intake or marine omega-3 PUFA intake with overall,
seropositive, or seronegative RA risk. We found a sug-
gestion that increasing fish intake may actually increase
RA risk for women diagnosed at age > 55 years. We iden-
tified a smoking-fish interaction, such that ever smokers
with frequent fish intake had only a modestly increased
earlier-onset RA risk compared to the very elevated RA
risk of smokers with infrequent fish intake. Our study
does not provide evidence to recommend fish or
omega-3 fatty acid intake to those at risk for RA.
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